Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells

Talar Tokatlian(Integrated BioTherapeutics (United States)), Alexander Kamb(Integrated BioTherapeutics (United States))
Journal for ImmunoTherapy of Cancer
January 1, 2022
10.1136/jitc-2021-003826
Cited by 64

Related Papers

No related papers found

Powered by citation graph analysis